Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: April 2023

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Presents Innovative Pipeline of Nanosized Antibody Treatments at Bio-Europe Spring Conference in Switzerland

Posted on April 18, 2023 by MissionIR

The EBD Group’s 17th annual Bio-Europe Spring Conference was held March 20-22, 2023, in Basel, Switzerland. The conference showcased three thematic pillars – the business of biotech, therapeutic insight tracks, and ecosystem influencers. The elite European bio-tech conference featured a … Continue reading →

Posted in BiondVax Pharmaceuticals Ltd. BVXV | Leave a comment

MissionIRNewsBreaks – Progressive Care Inc. (RXMD) Identified as a High-Growth Opportunity

Posted on April 17, 2023 by MissionIR

Progressive Care (OTCQB: RXMD) offers services and technology that supports the managed health care industry to reduce costs and improve the quality of care. “The company has been steadily building both its pharmacy and data-management divisions as revenues continue to … Continue reading →

Posted in Progressive Care Inc. RXMD | Leave a comment

MissionIRNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Releases Shareholder Update on Major Programs, M&A Plans

Posted on April 17, 2023 by MissionIR

Aditxt (NASDAQ: ADTX), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, has released a shareholder update outlining its three innovation programs and strategic M&A initiatives. The update notes that subsidiary Pearsanta submitted … Continue reading →

Posted in Aditxt Inc. ADTX | Leave a comment

MissionIRNewsBreaks – RYVYL Inc. (NASDAQ: RVYL) Plans to Release Q4, FY 2022 Financial Report Later Today

Posted on April 17, 2023 by MissionIR

RYVYL (NASDAQ: RVYL), a company that leverages the security of the blockchain and USD-pegged stablecoin technology with near-real-time attestation to conduct payment transactions, announced that it will release financial information later today. The financial report will for the fourth quarter … Continue reading →

Posted in RYVYL Inc. RVYL | Leave a comment

Data443 Risk Mitigation Inc.’s (ATDS) Award-Winning Ransomware Defense Shines as Cybercrime Persists

Posted on April 17, 2023 by MissionIR

Our increasing global dependence on digital infrastructure is a double-edged sword. While benefits like improved efficiencies, technological innovation and economic growth propel the transformation forward, it has also created a myriad of opportunities for cybercriminals. An expensive ecosystem is emerging, … Continue reading →

Posted in Data443 Risk Mitigation Inc. ATDS | Leave a comment

Cartier Silver Corp. (CSE: CFE) Follows in Eloro Resources Ltd.’s (TSX: ELO) (OTCQX: ELRRF) Footsteps Within Bolivia’s Potosi Region

Posted on April 17, 2023 by MissionIR

In October 2022, when Cartier Iron made a dramatic pivot within its business and amended its name to Cartier Silver (CSE: CFE), few would have guessed the impact that the change could have resulted in only a few months down … Continue reading →

Posted in Eloro Resources Ltd. ELRRF | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyes the Licensed Use of its DehydraTECH(TM) Technology to Complement its Royalty Earnings and Realize Revenue in Advance of Royalties

Posted on April 17, 2023 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has, since its inception, stayed committed to creating shareholder value and exploring different avenues for growth. This outlook has informed the company’s ambitious clinical studies, starting with the HYPER-H21-4 … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Demonstrates Positive Results in First Diabetes Study

Posted on April 14, 2023 by MissionIR

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is increasing the bioavailability of and improving the way that active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery with its patented DehydraTECH(TM). “Most … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Announces Q4 and Year-End 2022 Results

Posted on April 14, 2023 by MissionIR

D-Wave (NYSE: QBTS), a leader in quantum computing systems, software and services, and the only commercial provider building both annealing and gate-model quantum computers, today announced financial results for its fourth quarter and fiscal year ended Dec. 31, 2022. “We … Continue reading →

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

MissionIRNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Leveraging Innovative NanoAb Pipeline to Disrupt High-Value Market Opportunities

Posted on April 14, 2023 by MissionIR

BiondVax (NASDAQ: BVXV) is a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. “In many compelling ways, BiondVax punches well above its weight compared to biopharma companies of … Continue reading →

Posted in BiondVax Pharmaceuticals Ltd. BVXV | Leave a comment